Sense and nonsense concerning biotin interference in laboratory tests.

Published in: Acta clinica Belgica (2020)

Solutions to overcome this interference are: informing patients prior to analysis (avoiding peak biotin values when sampling), choice of appropriate immunoassays, and use of biotin removing steps prior to analysis.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
decision making